Small lymphocytic lymphoma
Synchronously diagnosed lymph nodal collision tumor of malignant melanoma and chonic lymphocytic leukemia/small lymphocytic lymphoma: case report
... chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma and malignant melanoma (MM) occurring synchronously in the same lymph ...
5
Primary central nervous system small lymphocytic lymphoma in the bilateral ventricles: two case reports
... Background: Primary central nervous system (CNS) small lymphocytic lymphoma (SLL), as a type of low-grade lymphoma, is extremely rare. The diagnosis of CNS SLL is challenging due to its ...
5
Small lymphocytic lymphoma with florid perniosis-like features: a case report
... by small to intermediate sized lym- phocytes with condensed chromatin, irregular nuclear contours and minimal cytoplasm ...B-cell lymphoma, such as small lymphocytic ...
5
Case Report Chronic myelogenous leukemia following small lymphocytic lymphoma: a case report and review of literature
... Abstract: Chronic myelogenous leukemia (CML) following non-Hodgkin’s lymphoma (NHL) is extremely rare. Here we report a unique case of CML after small lymphocytic lymphoma (SLL). A ...
6
NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma
... Chronic lymphocytic leukemia (B-CLL) and small lymphocytic lymphoma (SLL) are part of the same disease classification but are defined by differential distribution of tumor ...
14
<p>The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma</p>
... chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), both as a single agent and in combination with anti-CD20 immunotherapies, such as ...
9
<p>CD5-negative chronic lymphocytic leukemia/small lymphocytic lymphoma in a patient with gastrointestinal mantle cell lymphoma: an unusual case report</p>
... Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is common leukemia in adults and accounts for approximately 30% and 7% of lymphoid and nodal lymphomas, ...cell ...
5
www.ijcep.com /IJCEP704000 Case Report Composite Small Lymphocytic Lymphoma and Extra- medullary Myeloid Tumor: A Potential Diagnostic Pitfall
... composite small lymphocytic lymphoma (SLL) and extramedullary myeloid tumor (EMT) occurring in the same lymph ...of small mature lymphocytes with numerous irregularly dispersed nodules, ...
7
Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma
... chronic lymphocytic leukemia/small lym- phocytic lymphoma (CLL/SLL) into an aggressive form of non-Hodgkin lymphoma (NHL), most commonly into diffuse large B cell lymphoma (DLBCL), ...
7
Primary Small B-cell Lymphoma (MALT Lymphoma) at Lingual Tonsil: A Case Report Gaffar Aslan 1* , Tulay Tecimer 2, Sadik Server3 , Fikret Cinar 1 Sefik Igdem 4, Ipek Coban5 and Coskun Tecimer 6
... Hodgkin lymphoma (NHL), either of B-lymphocyte or T-lymphocyte in origin ...general, small B cell lymphoma is classified into Mantle cell lymphoma (MCL), Follicular lymphoma (FL), ...
9
<p>Follicular Lymphoma Presenting With Monoclonal IgM And MYD88 Mutation: A Case Report And Review Of The Literature</p>
... To date, no FL cases with MYD88 mutation have been reported. Okosun et al performed whole-genome or whole- exome sequencing on 10 pairs with the transformation of FL to DLBCL, followed by deep sequencing of 28 genes in ...
10
Hepatitis B and C viruses and risk of non-Hodgkin lymphoma: a case-control study in Italy
... B-cell lymphoma (DLBCL; OR = 4.08, 95 % CI: 2.46–6.76), marginal zone lymphoma (MZL; OR = ...phoplasmacytic lymphoma (LPL, OR = 8.43, 95 % CI: 2.26–31.52), and small lymphocytic ...
6
Case report: rare case of infiltration of small lymphocytic B-cell lymphoma in the thyroid gland of female patient with B-cell chronic lymphocytic leukemia (CLL-B/SLL-B)
... audible thyroid bruit. Lymph node packages with the diameter of 5 cm were palpable on the lateral surface of the neck, particularly on its left side. Hormone tests revealed normal levels of free thyroid hormones and ...
6
Case Report A case study of t(14;22)(q32;q11) involving immunoglobulin heavy and light chain in follicular lymphoma
... chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), 1 case of hairy cell leukemia (HCL), 1 case of HCL variant (HCL-v), 1 case of diffuse large B cell lymphoma (DLBCL), ...
7
Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients
... Anaplastic lymphoma kinase; cART: Combined antiretroviral therapy; CLL/SLL: Chronic lymphocytic leukemia/small lymphocytic lymphoma; CODOX-M/IVAC: Cyclophosphamide, vincristine, ...
11
<p>Immunochemotherapy for Richter syndrome: current insights</p>
... aggressive lymphoma during the clinical course of chronic lymphocytic leukemia/small lymphocytic lymphoma ...B-cell lymphoma (DLBCL-RS, 90%) and Hodgkin’s lymphoma (HL-RS, ...
14
B cell receptor pathway in chronic lymphocytic leukemia: specific role of CC-292
... Abstract: Chronic lymphocytic leukemia (CLL) is the most common adult leukemia. The current treatment paradigm involves the use of chemoimmunotherapy, when patients develop an indication for therapy. With this ...
10
Clinical Outcomes of 67 Patients Treated with Chemoradiotherapy for Primary Thyroid Non Hodgkin’s Lymphoma in Osaka Medical College
... When external irradiation using appropriate irradiation field by scintigraphy (Ga-67 citrate and F-18 FDG) is used, a dose of 36 Gy should be delivered as a preferred dose to prevent the recurrence of malignant ...
6
A critical appraisal of ibrutinib in the treatment of mantle cell lymphoma and chronic lymphocytic leukemia
... primary end point was overall response to treatment after six cycles of therapy at 24 weeks. With a median follow-up of 24 months, 41 (82%) patients are still on treatment with- out disease progression. Nine patients ...
12
Profile of venetoclax and its potential in the context of treatment of relapsed or refractory chronic lymphocytic leukemia
... The orally available BCL2 inhibitor venetoclax, formerly called ABT199, is restoring apoptosis in tumors by directly targeting the antiapoptotic BCL2 family proteins in CLL and B-cell non-Hodgkin lymphoma (BNHL) ...
12